PRESS RELEASE Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported OutcomesFirst conceptual ...

Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker Essential Pharma that will provide funds to expand its product portfolio and ...

Agomab Therapeutics has closed a $100 million third-round financing, heading a list of recent funding rounds that also features AstronauTx, MinervaX, Precede Bio and LimmaTech. Belgium-based Agomab ...

HAMILTON, ON, Nov. 12, 2025 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that it has successfully supplied the first dose of Ariceum Therapeutics ...

Built in California, powered by Linux, the Liberty Phone says no to tech giants With no Android or iOS, it’s the loneliest smartphone on the market today It costs more, does less, and still claims to ...

A California-based company has come out with a smartphone that is almost entirely manufactured in the US, although it uses lower quality parts and its technology can’t compete with the iPhone — and it ...

The Trump Organization made headlines last week when it announced the launch of Trump Mobile, a cell service with plans to release a gold T1 phone in September. One of its selling points, according to ...

The Liberty Phone's motherboard is made in-house, while its chip is sourced from Texas. The final assembly takes place at Purism's facility in Carlsbad, California. However, not all parts are sourced ...

Biotech-focused investment firm Frazier Life Sciences has launched Callio Therapeutics, a cancer treatment startup with headquarters in Seattle and Singapore. Frazier led a $187 million Series A round ...

Frazier Life Sciences has launched Callio Therapeutics with $187 million in series A funds and a HER2-targeted dual-payload antibody-drug conjugate that’s ready for the clinic. The ADC, and Callio’s ...

PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, ...